Magnera Corp (MAGN) - Q2 2026 10-Q Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 28, 2026, and the two quarterly periods ended March 28, 2026 (Year-to-Date). Magnera Corporation operates in two reportable segments: Americas and Rest of World. The company manufactures personal care and consumer solution products, including medical garments, wipes, filtration, and incontinence products. The financial statements reflect the post-merger status following the November 2024 merger with Glatfelter Corporation.
Key Financial Metrics
| Metric | Q2 2026 (Quarter) | Q2 2025 (Quarter) | YTD 2026 (2 Quarters) | YTD 2025 (2 Quarters) |
|---|---|---|---|---|
| Net Sales | $796 million | $824 million | $1,588 million | $1,526 million |
| Operating Income | $17 million | $4 million | $31 million | $(18) million |
| Net Loss | $(18) million | $(41) million | $(52) million | $(101) million |
| Adjusted EBITDA | $90 million | $89 million | $183 million | $173 million |
| Cash from Operations (YTD) | $89 million (YTD 2026) vs $7 million (YTD 2025) | |||
| Free Cash Flow (YTD) | $60 million (YTD 2026) | |||
| Long-Term Debt | $1,899 million (as of March 28, 2026) | |||
| Cash & Equivalents | $303 million (as of March 28, 2026) |
Material Changes vs. Prior Period
- Revenue: Q2 net sales declined 3% ($28 million) year-over-year due to a $57 million decrease in selling prices (product mix and lower raw material pass-through) and a 2% organic volume decline. This was partially offset by $48 million in favorable foreign currency impacts.
- Profitability: Operating income improved significantly to $17 million from $4 million in the prior year quarter, driven by a $7 million reduction in business integration costs and $6 million lower depreciation/amortization.
- Segment Performance:
- Americas: Sales down 8% due to winter storm disruptions and lower prices; Adjusted EBITDA down 9% due to unfavorable price/cost spread.
- Rest of World: Sales up 2% driven by favorable currency ($37 million); Adjusted EBITDA up 28% due to synergy realization and mix improvement.
- Restructuring: Restructuring charges were $16 million for the quarter and $38 million YTD, down from $23 million and $55 million in the prior year periods, respectively.
Guidance, Outlook, and Risks
Outlook: Management projects fiscal year 2026 cash from operations between $170 million and $190 million, and free cash flow between $90 million and $110 million, assuming $80 million in capital spending.
Risks and Contingencies:
- Internal Controls: Management concluded that disclosure controls and procedures were not effective as of March 28, 2026, due to deficiencies related to the 2024 merger integration and legacy IT systems. Remediation is ongoing.
- Market Risks: Exposure to interest rate fluctuations (SOFR-based debt) and foreign currency volatility (Euro, Brazilian Real, Argentine Peso). A 10% decline in foreign currency rates would have a favorable $8 million impact on net income.
- Contingencies: Outstanding environmental liability of $17 million (Fox River, WI) and potential tax claim settlements up to $63 million related to a prior acquisition.
- Operational Risks: Supply chain disruptions, raw material costs, and general market softness in Europe and South America.
Investor Verification Checklist
- Verify the timeline and progress of remediation for the ineffective internal controls over financial reporting.
- Monitor the organic volume decline (2% Q2, 4% RoW YTD) to assess if market softness is a temporary or structural issue.
- Review the debt maturity profile ($1.9B total) and the company's plan to refinance obligations prior to maturity.
- Assess the impact of foreign currency fluctuations on future earnings, given the significant exposure to non-U.S. operations.
- Track the realization of synergies from the 2024 merger, which currently supports Adjusted EBITDA growth in the Rest of World segment.